Must Reads by Date
Must reads for theWeek ending November 1, 2015
Mild Traumatic Brain Injury and PTSD, Does it have prognostic value?
Brivaracetam and Partial-Onset Seizures, Studying efficacy and tolerance
PTSD in Patients With Migraine, Assessing the impact
Sleep Apnea and Cardiovascular Surgery, Does it affect outcomes?
Imaging Assessments vs Outcomes in Stroke, Evaluating mismatch profiles
Must reads for theWeek ending October 25, 2015
Oligoclonal Bands and Multiple Sclerosis, Assessing their significance in patients with CIS
Cladribine in Multiple Sclerosis, Does it confer cancer risk?
MOG-Ab in Inflammatory Demyelinating Disease, Evaluating its utility as biomarker
Vitamin D and Multiple Sclerosis, Studying associations with regulatory variants
Statins in RRMS Therapy, Is there benefit to their addition?
Must reads for theWeek ending October 18, 2015
Vitamin D-related Factors in MS, Studying the effects in Denmark
Brain Atrophy in MS, Observing changes over time
Total Sodium Concentration in MS Brains, Does it indicate severity?
Natalizumab in RRMS, Researching lymphocytosis as an efficacy biomarker
Depression in MS, Correlating differences with limbic system functions
Must reads for theWeek ending October 11, 2015
Pixantrone in Active Multiple Sclerosis, After immunomodulatory therapy fails
SNPs Associated With Interferon Beta Response, Which may have predictive value?
BMI and Interferon Beta Response, Associating mass with disease status
Vitamin D and Immunomodulatory Therapies, Studying effects on inflammation markers
Progranulin Genetic Polymorphisms and Disease Course, What influence do they exert?
Must reads for theWeek ending October 4, 2015
2D:4D Ratio as Predictor of MS Status, Assessing the associations
MS Lesion Formation, Weekly MRIs show their evolution
Smoking Cessation in Prevalent MS, How does it affect prognosis?
Interferon Therapy in SPMS, Analyzing its efficacy
Disability Progression in MS, Is response to cytomegalovirus a positive factor?